by Pill Pals | Mar 11, 2025 | News
Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released. Author affiliation: National Brucella Reference Laboratory, Kimron Veterinary Institute,...
by Pill Pals | Mar 11, 2025 | News
Delivery Method: VIA EMAIL CONFIRMED DELIVERY Product: Drugs Recipient: Recipient Name Evan Gilbert Right Value Drug Stores, LLC dba Carie Boyd Pharmaceuticals 2501 W. Oak StreetDenton, TX 76201United States Issuing Office: Center for Drug Evaluation and Research...
by Pill Pals | Mar 11, 2025 | News
Delivery Method: Via Email Product: Drugs Recipient: Recipient Name Joseph Young Pico IV Inc. 1610 R St. Ste 300Sacramento, CA 95811United States Support@picoiv.com Issuing Office: Center for Drug Evaluation and Research (CDER) United States WARNING LETTERMarch 6,...
by Pill Pals | Mar 11, 2025 | News
Delivery Method: VIA Electronic Mail Reference #: 320-25-49 Product: Drugs Recipient: Recipient Name Mr. V. Vishnu Murthy Raju Recipient Title Managing Director Shree Jaya Laboratories PVT. LTD. Plot No. 11, Road No. 3, ALEAP Industrial EstateNear Pragathi Nagar,...
by Pill Pals | Mar 11, 2025 | News
Potential applicants are encouraged to contact the FDA Generic Drugs Program with questions at any point in their development and ANDA preparation processes.For inquiries related to ANDAs pending filing review and the status of pending suitability petitions, please...
by Pill Pals | Mar 11, 2025 | News
AUDIENCE: Patient, Health Professional, Pharmacy, ImmunologyISSUE: As a precautionary measure, the following lots of Immune Globulin Intravenous (IGIV) and Immune Globulin Subcutaneous (IGSC) have been voluntarily withdrawn by the manufacturers due to a higher rate of...